Interesting study. I hope the company adresses this publicly at some point. Possibly at the next non-calcification milestone.
Not necessarily bad news, as long as we are the best product on the market it will ultimately become the first choice for surgeons. Time will tell but it is clearly increasing in popularity.
oral presentation- ADAPT in AV reconstruction in CHD, page-13
-
- There are more pages in this discussion • 57 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.20 |
Change
0.000(0.00%) |
Mkt cap ! $330.6M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6 | $17.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.00 | 2 | 1 |
View Market Depth
| Last trade - 09.36am 18/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |
Day chart unavailable